145 related articles for article (PubMed ID: 7788986)
1. Evaluation of bone metastases by Tc-99m MDP imaging in patients with stomach cancer.
Choi CW; Lee DS; Chung JK; Lee MC; Kim NK; Choi KW; Koh CS
Clin Nucl Med; 1995 Apr; 20(4):310-4. PubMed ID: 7788986
[TBL] [Abstract][Full Text] [Related]
2. Skeletal metastases mimicking a bilateral "delta sign" on Tc-99m MDP bone scintigraphy.
Lim ST; Sohn MH; Kwak JY; Yim CY
Clin Nucl Med; 2001 Jun; 26(6):573-4. PubMed ID: 11353320
[No Abstract] [Full Text] [Related]
3. Intraindividual Comparison of
Rathke H; Afshar-Oromieh A; Giesel FL; Kremer C; Flechsig P; Haufe S; Mier W; Holland-Letz T; De Bucourt M; Armor T; Babich JW; Haberkorn U; Kratochwil C
J Nucl Med; 2018 Sep; 59(9):1373-1379. PubMed ID: 29371410
[TBL] [Abstract][Full Text] [Related]
4. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
Qiu ZL; Xue YL; Song HJ; Luo QY
Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
[TBL] [Abstract][Full Text] [Related]
6. [Bone scintigraphy in bone metastases due to prostatic cancer].
Hidaka H; Ishino Y; Nakayama C; Nakata H; Okamura T
J UOEH; 1987 Dec; 9(4):369-77. PubMed ID: 3438611
[TBL] [Abstract][Full Text] [Related]
7. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
8. Comparing whole body 18F-2-deoxyglucose positron emission tomography and technetium-99m methylene diophosphate bone scan to detect bone metastases in patients with non-small cell lung cancer.
Hsia TC; Shen YY; Yen RF; Kao CH; Changlai SP
Neoplasma; 2002; 49(4):267-71. PubMed ID: 12382027
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-antigranulocyte bone marrow scintigraphy of breast and prostate skeletal metastases.
Limouris GS; Voliotopoulos V; Stavraka A; Vlahos L
Anticancer Res; 1997; 17(3B):1615-8. PubMed ID: 9179204
[TBL] [Abstract][Full Text] [Related]
10. Potential of (99m)Tc-MIBI for detecting bone marrow metastases.
Wakasugi S; Noguti A; Katuda T; Hashizume T; Hasegawa Y
J Nucl Med; 2002 May; 43(5):596-602. PubMed ID: 11994520
[TBL] [Abstract][Full Text] [Related]
11. Tc-99m MDP and Tc-99m MIBI dual imaging of photopenic bone metastases of carcinoma of the larynx.
Berk F; Demir H; Erdincler O; Isgoren S; Aktolun C
Clin Nucl Med; 2002 Jun; 27(6):442-3. PubMed ID: 12045441
[No Abstract] [Full Text] [Related]
12. Technetium-99m MDP scintigraphy. An insensitive tool for the detection of bone marrow metastases.
Gulenchyn KY; Papoff W
Clin Nucl Med; 1987 Jan; 12(1):45-6. PubMed ID: 3815996
[TBL] [Abstract][Full Text] [Related]
13. Bone scans with one or two new abnormalities in cancer patients with no known metastases: frequency and serial scintigraphic behavior of benign and malignant lesions.
Jacobson AF; Cronin EB; Stomper PC; Kaplan WD
Radiology; 1990 Apr; 175(1):229-32. PubMed ID: 2315486
[TBL] [Abstract][Full Text] [Related]
14. Differentiation of malignant and degenerative benign bone disease using Tc-99m MDP and Tc-99m citrate scintigraphy.
Sharma R; Mondal A; Bhatnagar A; Chakravarty KL; Mishra P; Chopra MK; Rawat HS; Kashyap R
Clin Nucl Med; 1998 Nov; 23(11):758-63. PubMed ID: 9814564
[TBL] [Abstract][Full Text] [Related]
15. Carcinoma of the stomach with osseous and extra-osseous metastases. Visualization of primary and secondary sites with Tc-99m medronate.
McLean RG
Clin Nucl Med; 1985 Mar; 10(3):199-200. PubMed ID: 2985323
[No Abstract] [Full Text] [Related]
16. Bone scan as a stratification variable in advanced prostate cancer.
Knudson G; Grinis G; Lopez-Majano V; Sansi P; Targonski P; Rubenstein M; Sharifi R; Guinan P
Cancer; 1991 Jul; 68(2):316-20. PubMed ID: 2070330
[TBL] [Abstract][Full Text] [Related]
17. Bone scintigraphy in nasopharyngeal carcinoma.
Sundram FX; Chua ET; Goh AS; Toh HJ; Khor TH; Chua EJ
Clin Radiol; 1990 Sep; 42(3):166-9. PubMed ID: 2208925
[TBL] [Abstract][Full Text] [Related]
18. Bone metastases demonstrated by pentavalent Tc-99m DMSA and Tc-99m HMDP.
Hirano T; Otake H
Clin Nucl Med; 1997 Sep; 22(9):640-1. PubMed ID: 9298304
[No Abstract] [Full Text] [Related]
19. [Whole-body bone scintigraphy in the diagnosis and follow-up of the evolution of breast cancer].
Muşat E; Stefănescu C; Rusu V
Rev Med Chir Soc Med Nat Iasi; 1999; 103(1-2):163-9. PubMed ID: 10756905
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma.
Kashyap R; Babbar A; Sahai I; Prakash R; Soni NL; Chauhan UP
Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
